This guideline updates and widens the scope of the previ-ous British Society for Haematology (BSH) Clinical guide-lines for Diagnosis and Management of Heparin-Induced Thrombocytopenia: Second Edition1 to include functional assays in the diagnosis of heparin-induced thrombocy...
McLornan, Donal P;
Psaila, Bethan;
Ewing, Joanne;
Innes, Andrew;
Arami, Siamak;
Brady, Jessica;
Butt, Nauman M;
Cargo, Catherine;
Cross, Nicholas C. P;
Francis, Sebastian;
Frewin, Rebecca;
Garg, Mamta;
Godfrey, Anna L;
Green, Anna;
Khan, Alesia;
Knapper, Steve;
Lambert, Jonathan;
McGregor, Andrew;
McMullin, Mary Frances;
Nangalia, Jyoti;
Neelakantan, Pratap;
Woodley, Claire;
Mead, Adam;
Somervaille, Tim C. P;
Harrison, Claire N.
This document represents an update of the British Society for Haematology guideline on Myelofibrosis first published in 2012 and updated in 2015 These guidelines aim to pro-vide healthcare professionals with clear guidance on stratified management for primary myelofibrosis (PMF)...
The COVID-19 Treatment Guidelines were developed to provide clinicians with guidance on caring for
patients with COVID-19. Because clinical information about the optimal management of COVID-19
is evolving quickly, these Guidelines are updated frequently to reflect newly published data and other
authorita...
The Stroke Foundation is a national charity that partners with the community to prevent, treat and beat stroke. We
stand alongside stroke survivors and their families, healthcare professionals and researchers. We build community
awareness and foster new thinking and innovative treatments. We support surv...
Inactivated Vero cell culture-derived Japanese encephalitis vaccine (JE-VC [manufactured as IXIARO]) is the only JE vaccine licensed and available in the United States. JE-VC is manufactured by Intercell Biomedical (Livingston, United Kingdom) and distributed in the United States private market by Novart...
Antiplatelet and antithrombotic
medication management before, during, and after
neurointerventional procedures has significant practice
variation. This document updates and builds upon the
2014 Society of NeuroInterventional Surgery (SNIS)
Guideline ’Platelet function inhibitor and platelet
function te...
Lavonas, Eric J;
Akpunonu, Peter D;
Arens, Ann M;
Babu, Kavita M;
Cao, Dazhe;
Hoffman, Robert S;
Hoyte, Christopher O;
Mazer-Amirshahi, Maryann E;
Stolbach, Andrew;
St-Onge, Maude;
Thompson, Trevonne M;
Wang, George Sam;
Hoover, Amber V;
Drennan, Ian R.
In this focused update, the American Heart Association provides updated guidance for resuscitation of patients with cardiac arrest, respiratory arrest, and refractory shock due to poisoning. Based on structured evidence reviews, guidelines are provided for the treatment of critical ...
Papi, Alberto;
Ferreira, Diogenes S.;
Agache, Ioana;
Baraldi, Eugenio;
Beasley, Richard;
Brusselle, Guy;
Coleman, Courtney;
Gaga, Mina;
Gotera Rivera, Carolina Maria;
Melén, Erik;
Pavord, Ian D.;
Peñate Gómez, Deborah;
Schuermans, Daniel;
Spanevello, Antonio;
Tonia, Thomy;
Schleich, Florence.
Recent clinical trials of as-needed fixed-dose combination of inhaled corticosteroid (ICS)/formoterol have provided new evidence that may warrant a reconsideration of current practice. A Task Force was set up by the European Respiratory Society to provide evidence-based recommendations on the use of as-n...
Ra, Jin H;
Rattan, Rishi;
Patel, Nimitt J;
Bhattacharya, Bishwajit;
Butts, Christopher A;
Gupta, Shailvi;
Asfaw, Sofya H;
Como, John J;
Sahr, Sheryl M;
Bugaev, Nikolay.
Recent studies have evaluated outcomes associated with duration of antimicrobial treatment for complicated intra-abdominal infections (cIAI). The goal of this guideline was to help clinicians better define appropriate antimicrobial duration in patients who have undergone definitive source control for cIA...
Pavlick, Anna C;
Ariyan, Charlotte E;
Buchbinder, Elizabeth I;
Davar, Diwakar;
Gibney, Geoffrey T;
Hamid, Omid;
Hieken, Tina J;
Izar, Benjamin;
Johnson, Douglas B;
Kulkarni, Rajan P;
Luke, Jason J;
Mitchell, Tara C;
Mooradian, Meghan J;
Rubin, Krista M;
Salama, April K. S;
Shirai, Keisuke;
Taube, Janis M;
Tawbi, Hussein A;
Tolley, J Keith;
Valdueza, Caressa;
Weiss, Sarah A;
Wong, Michael K;
Sullivan, Ryan J.
Since the first approval for immune checkpoint inhibitors
(ICIs) for the treatment of cutaneous melanoma more than
a decade ago, immunotherapy has completely transformed
the treatment landscape of this chemotherapy-resistant
disease. Combination regimens including ICIs directed
against programmed cell de...
